{
  "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9",
  "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 23,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "go_to_market",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide uses a bulleted list to detail the partnership strategy, focusing on leveraging existing lab infrastructure to minimize marketing overhead.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/11",
  "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9",
  "deckJsonHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9.json",
  "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.31,
        "x": 0.52,
        "y": 0.93
      },
      "kind": "disclaimer",
      "text": "Past performance is not indicative of future results. Investments may be speculative, illiquid, and there is a risk of principal loss. There is no guarantee that any specific outcome will be achieved.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02952884-1bc4-46c4-a2c1-f9eb59eb1555",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.72,
        "w": 0.42,
        "x": 0.55,
        "y": 0.185
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20fbc1ce-3f28-437b-a914-dc0c0b1336e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.47,
        "x": 0.02,
        "y": 0.24
      },
      "kind": "list",
      "text": "Targeting the top 10 global pathology labs such as Sonic Healthcare and Limbach Group (already Mainz BioMed's clients in Germany). Unlike the large centralized laboratory competitors, Mainz BioMed aims to offer sales of FDA approved test kits to regional/national laboratory service providers across America. The largest US-based laboratory chains could provide rapid market penetration and revenue. The 5 largest labs alone represent $37.6B in annual diagnostics revenue. Most US clinical labs have strong sales & marketing departments, and if ColoAlert is private labeled, limited marketing effort would be required from Mainz BioMed to general practitioners and patients. Marketing materials co-branded for lab partners could include lab-specific consumer messaging. ColoAlert provides laboratory partners with an excellent ability to position themselves as leaders in cutting-edge technology.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f71aa63f-ddbd-41ac-be22-5a29366abf02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "11 marketwatch.com report: Clinical Laboratory Services Market 2020 Global Analysis, Opportunities And Forecast To 2025. LabCorp ($11.5B), Sanofi Genzyme ($8.1B), Quest Diagnostics ($7.75B), Abbott Laboratories ($7.7B) and Charles River ($2.6B)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25c97d09-6a7c-4285-af4c-cf476cf82ba0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.36,
        "x": 0.03,
        "y": 0.11
      },
      "kind": "title",
      "text": "Maximizing Current & Future Partnerships",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c2d0d6d-8250-4a0a-975d-3215bd726fce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.46,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "COMMERCIALIZATION STRATEGY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ff39a4b-4ff9-4cc2-a54a-b6e4bef891b5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 12,
      "from": 10,
      "beatId": "b6ce095a-2569-4613-b6ea-05637d9e9e17",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, calling for action",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "81ffe8fb-6e04-4bb2-b668-9b0f1dd6692c",
      "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, highlighting quick wins and big bets",
      "position": 1,
      "objective": "What are the quick wins and big bets for ColoAlert's commercialization?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}